Vladimir Matchkov

The vascular Ca2+-sensing receptor regulates blood vessel tone and blood pressure

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  • Martin Schepelmann, School of Biosciences, Cardiff University, United Kingdom
  • Polina L Yarova, School of Biosciences, Cardiff University, United Kingdom
  • Irene Lopez-Fernandez, School of Biosciences, Cardiff University, Department of Pathophysiology and Allergy Research, Medical University of Vienna, United Kingdom
  • Thomas S Davies, School of Biosciences, Cardiff University, United Kingdom
  • Sarah C Brennan, School of Biosciences, Cardiff University, United Kingdom
  • Peter J Edwards, School of Biosciences, Cardiff University, United Kingdom
  • Abhishek Aggarwal, Department of Pathophysiology and Allergy Research, Medical University of Vienna, Austria
  • Joao Graca, School of Biosciences, Cardiff University, Pathology Sciences, AstraZeneca, United Kingdom
  • Katja Rietdorf, Faculty of Science, Department for Life, Health and Chemical Sciences, The Open University, Milton Keynes, United Kingdom
  • Vladimir V Matchkov
  • Robert A Fenton
  • Wenhan Chang, Endocrine Research Unit, Department of Veteran Affairs Medical Center, Department of Medicine, University of California, United States
  • Martin Krssak, Division of Endocrinology and Metabolism, Department of Medicine III, Medical University of Vienna, Austria
  • Andrew Stewart, School of Biosciences, Cardiff University, United Kingdom
  • Kenneth J Broadley, School of Pharmacy and Pharmaceutical Sciences, Division of Pharmacology, Cardiff University, United Kingdom
  • Donald T Ward, Faculty of Life Sciences, University of Manchester, United Kingdom
  • Sally A Price, Pathology Sciences, AstraZeneca, United Kingdom
  • D H Edwards, Cardiff University, Wales Heart Research Institute, United Kingdom
  • Paul J Kemp, School of Biosciences, Cardiff University, United Kingdom
  • Daniela Riccardi, School of Biosciences, Cardiff University, United Kingdom

The extracellular calcium-sensing receptor, CaSR, is expressed in blood vessels where its role is not completely understood. In this study, we tested the hypothesis that the CaSR expressed in vascular smooth muscle cells (VSMC) is directly involved in regulation of blood pressure and blood vessel tone. Mice with targeted CaSR gene ablation from vascular smooth muscle cells (VSMC) were generated by breeding exon 7 LoxP-CaSR mice with animals in which Cre recombinase is driven by a SM22α promoter (SM22α-Cre). Wire myography performed on Cre-negative (wild-type, WT) and Cre-positive (SM22α)CaSR(∆flox/∆flox) (knock-out, KO) mice showed and endothelium-independent reduction in aorta and mesenteric artery contractility of KO compared to WT mice in response to KCl and to phenylephrine. Increasing extracellular calcium ion (Ca(2+)) concentrations (1-5 mM) evoked contraction in WT, but only relaxation in KO aortae. Accordingly, diastolic and mean arterial blood pressures of KO animals were significantly reduced compared to WT, as measured by both tail cuff and radiotelemetry. This hypotension was mostly pronounced during the animals' active phase and was not rescued by either NO-synthase inhibition with L-NAME or by a high salt-supplemented diet. KO animals also exhibited cardiac remodeling, bradycardia and reduced spontaneous activity in isolated hearts and cardiomyocyte-like cells. Our findings demonstrate a role for CaSR in the cardiovascular system and suggest that physiologically relevant changes in extracellular Ca(2+) concentrations could contribute to setting blood vessel tone levels and heart rate by directly acting on the cardiovascular CaSR.

Original languageEnglish
JournalAmerican Journal of Physiology: Cell Physiology
Volume310
Issue3
Pages (from-to)C193-C204
Number of pages12
ISSN0363-6143
DOIs
Publication statusPublished - 1 Feb 2016

See relations at Aarhus University Citationformats

ID: 95643149